Trending News

Gene Therapy Offers New Hope for Retinitis Pigmentosa Patients

Gene Therapy Offers New Hope for Retinitis Pigmentosa Patients

What Did the Research Discover? Researchers studied retinitis pigmentosa (RP), an inherited eye disease that causes vision loss due to the death of light-sensitive cells in the retina. RP affects about 1 in 5,000 people worldwide, leading to symptoms like night blindness and tunnel vision. The condition is caused by genetic mutations, and more than 90 genes have...

Opioids and Acute Low Back Pain: Key Risk Factors for Ongoing Discomfort

Opioids and Acute Low Back Pain: Key Risk Factors for Ongoing Discomfort

What did the research discover? This study found that nearly one-third (32%) of patients with acute low back pain (LBP) transitioned to chronic LBP within six months. The risk of developing chronic pain was significantly associated with: Higher scores on the Subgroups for Targeted Treatment Back Tool (SBT), which predicts persistent functional limitations. Exposure...

Elafibranor: A Promising New Treatment for Primary Biliary Cholangitis

Elafibranor: A Promising New Treatment for Primary Biliary Cholangitis

What Did the Research Discover? Primary biliary cholangitis (PBC) is a rare liver disease that gradually damages the bile ducts, leading to liver scarring. If left untreated, it can progress to cirrhosis and severe liver disease. The current first-line treatment, ursodeoxycholic acid (UDCA), does not work for up to 40% of patients, and the second-line option,...

FDA News Update: Nationwide Shift to Natural Food Dyes Begins

FDA News Update: Nationwide Shift to Natural Food Dyes Begins

For Immediate Release: April 22, 2025 The U.S. Department of Health and Human Services and U.S. Food and Drug Administration (FDA) today announced a series of new measures to phase out all petroleum-based synthetic dyes from the nation’s food supply—a significant milestone in the administration’s broader initiative to Make America Healthy Again. The FDA is taking...

Revolutionary Eye Drops May Offer Future Non-Surgical Treatment for Cataracts

Revolutionary Eye Drops May Offer Future Non-Surgical Treatment for Cataracts

What Did the Research Discover? Cataracts are a leading cause of vision loss worldwide, affecting millions of people. As people age, the risk of developing cataracts increases, and while surgery is effective, it is expensive and not always available in all areas. Because of this, researchers are looking for medications that could help prevent or treat cataracts...

Magnetic Seizure Therapy: A Promising Treatment for Major Depression

Magnetic Seizure Therapy: A Promising Treatment for Major Depression

What did the research discover? Researchers studied two different treatments for major depressive disorder (MDD): Magnetic Seizure Therapy (MST) and Electroconvulsive Therapy (ECT). They wanted to see which one worked better for treating depression and which had fewer effects on memory and thinking skills. The study gathered data from 10 different studies, including...